consensu hope turnaround sustain
us knee implant sale remain concern
placement total ww growth keep dream aliv sale
improv sequenti mil roughli line estim clear
import hurdl investor look robot assist turnaround
knee busi said y/i declin knee growth suggest
turnaround underli knee implant growth rate still least quarter two away
continu view zbh robot strategi knee turnaround signific challeng
oper riski particularli compar diversifi growth pipelin
driver see large-cap med tech name univers henc continu
prefer risk-reward profil current trade
modest premium in-lin respect ev/ebitda basi reiter
under-perform rate target price
lose anoth us knee implant share in-lin
trend estim america knee implant sale declin adjust
mil robot sale report us knee sale line benefit
extra sell day quarter management cite continu view
return sustain growth underli us knee implant growth market
growth rate critic turnaround zbh ortho busi
chang model weve made minor chang top-lin estim increas
ep estim total year sale estim declin
averag ep estim declin averag driven lower
valuat tp base ev/ebitda multipl ntm ebitda
bil one year forward reflect higher market sector multipl risk re-
acceler us knee implant sale faster uptak rosa knee
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
mariu zoican univers toronto rotman school manag novemb
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
inc global manufactur provid
medic devic equip treatment musculoskelet
spinal disord trauma dental implant
one-year valuat scenario base
ev/ebitda ebitda
scenario base high-growth segment grow
growth grow
one-year valuat grey scenario base
ev/ebitda grey ebitda grey
scenario base high-growth segment grow
growth grow
 close
mariu zoican univers toronto rotman school manag novemb
addit detail takeaway
knee roughli in-lin mil y/i
america knee sale mil mil increas emea sale mil
mil cc apac sale mil mil increas cc
compani receiv fda approv persona revis system slightli tougher fx
neg impact report sale quarter analysi estim compani
report mil rosa revenu mil grew ww
busi cc base estim believ compani lost around
bp knee share loss see figur
figur analysi selling-day-adjust ortho market growth indic continu knee share loss
us knee implant growth adjust estim mil robot sale report compani knee sale line
hip better expect mil mil
america hip sale mil mil increas cc emea sale
mil mil cc apac sale mil mil increas
cc base analysi estim zbh share ww hip
stabl see
set sale mil mil y/i cc vs cse growth
driven suppli stabil new product launch increas special sale forc
product spine cmf sale mil mil decreas y/i cc vs
cse busi continu grow market management expect
momentum shift sometim dental revenu mil mil
y/i cc vs cse driven execut well target invest
key area sale mil mil y/i cc vs cse
apac emea led upsid off-set america
geograph america sale bil mil cc driven new
product introduct suppli stabil commerci execut emea sale mil
mktqtrli chgcc mktqtrli chgvar toest act estimate act estimate act estimate act growth bp growth bp estimate kneeskne market estimate knee market act us y/i share gains-to-loss growth y/i share gains-to-loss growth y/i share gains-to-loss market estimate hip market act us y/i share gains-to-loss growth y/i share gains-to-loss growth y/i share gains-to-loss mariu zoican univers toronto rotman school manag
mil increas cc apac sale mil mil driven
strength emerg market knee
compani maintain guidanc report sale growth guidanc flat
cc sale growth fx expect high-end
previou rang bp sell day differ primarili off-set
compani expect small neg impact bp point bottom-lin also
maintain ep guidanc
 oper margin bp estim
sale net cog lower sg deliv in-lin ep rel
estim beat street gross margin bp estim bp
y/i driven benefit onetim revers prior period medic devic excis
tax line management commentari prior quarter
estimate bpop bpnon-op bpnet chg y/i mariu zoican univers toronto rotman school manag novemb
salesy/i chg cc cg salesy/i chg cc estimate varianc mariu zoican univers toronto rotman school manag novemb
chang model
made minor adjust sale estim increas ep estim
lower year sale estim averag also reduc
year ep estim averag driven primarili lower gross margin assumpt
figur chang model
knee implant rosa system mariu zoican univers toronto rotman school manag novemb
compani mention price
matt miksic vik chopra certifi respect compani secur individu analyz view express
report accur reflect person view subject compani secur part
compens directli indirectli relat specif recommend view express report
